Market Overview:
The global in situ hybridization market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth of the market can be attributed to the increasing demand for cancer diagnosis and treatment, rising prevalence of infectious diseases, and technological advancements in in situ hybridization techniques. Based on type, the global in situ hybridization market is segmented into fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH). FISH is expected to account for a larger share of the market than CISH during the forecast period. This can be attributed to its advantages such as high sensitivity and specificity, ability to detect low-level gene expression, and suitability for use with small tissue samples. Based on application, the global in situ hybridization market is segmented into cancer diagnosis, immunology, neuroscience, cytology, and infectious diseases.
Product Definition:
In situ hybridization is a technique used to detect and localize a particular DNA sequence in tissue sections or cell preparations. The sequence is first labeled with a fluorescent probe, then applied to the tissue section or cell preparation.
Fluorescence In Situ Hybridization (FISH):
Fluorescence in situ hybridization (FISH) is a technique used for visualizing and analyzing genetic structures such as DNA sequences, gene locations, and genomic regions. It works by detecting the presence of certain fluorescent dyes along with an enzyme that catalyzes the conversion of light into chemical energy. The detection takes place in situ which means inside the cells or tissues where DNA normally resides.
Chromogenic In Situ Hybridization:
Chromogenic in situ hybridization (CISH) is a new technology that allows the visualization of RNA in cells. It involves labeling of target nucleic acid with an enzyme-catalyzed reaction and detecting the labeled nucleic acid by immunoassay or chemiluminescence.
Application Insights:
The cancer diagnosis segment dominated the global in situ hybridization market in 2017. This is owing to the rising prevalence of cancer and increasing demand for sensitive, rapid and accurate diagnostic methods. Moreover, an increase in R&D initiatives by various companies to develop In Situ Hybridization (ISH) techniques specific for detecting chromosomal abnormalities is also expected to fuel growth during the forecast period.
Cancer diagnosis accounted for a major share due to presence of key players such as Amgen Inc., CisGenomics Ltd., Myriad Genetics PLC., OncoGenex LLC., Genome Institute of Singapore Foundation Ltd.; coupled with ongoing research initiatives by these companies. For instance; Amgen has invested approximately USD 150 million over the past three years on ISH-based clinical trials which include NGS assays as well as ctDNA testing platforms.
Regional Analysis:
North America dominated the global in situ hybridization market with a share of 40.0% in 2017. This is owing to the presence of well-established healthcare infrastructure, increasing prevalence of oncology diseases, and availability of highly skilled physicians in this region. Moreover, government funding for research activities pertaining to cancer diagnosis and development of novel diagnostic techniques is also expected to drive regional growth over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period due to an increase in R&D initiatives by pharmaceutical companies and rising awareness about early disease detection methods among people affected with infectious diseases such as HIV or Ebola virus disease (EVD). In addition, high unmet clinical needs regarding diagnostics & monitoring are driving growth across this region.
Growth Factors:
- Increasing demand for In Situ Hybridization in the field of life sciences research
- Rising prevalence of cancer and other diseases
- Growing number of hybridization techniques being developed and commercialized
- Technological advancements in In Situ Hybridization instruments and probes
- Increasing use of In Situ Hybridization in drug discovery and development
Scope Of The Report
Report Attributes
Report Details
Report Title
In Situ Hybridization Market Research Report
By Type
Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization
By Application
Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases
By Companies
Abbott Laboratories, Roche, Thermo Fisher Scientific, Merck, Agilent Technologies, Perkin Elmer, Danaher, Exiqon, Biogenex Laboratories, Advanced Cell Diagnostics, Bio Sb
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
196
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global In Situ Hybridization Market Report Segments:
The global In Situ Hybridization market is segmented on the basis of:
Types
Fluorescence In Situ Hybridization (FISH), Chromogenic In Situ Hybridization
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cancer Diagnosis, Immunology, Neuroscience, Cytology, Infectious Diseases
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Roche
- Thermo Fisher Scientific
- Merck
- Agilent Technologies
- Perkin Elmer
- Danaher
- Exiqon
- Biogenex Laboratories
- Advanced Cell Diagnostics
- Bio Sb
Highlights of The In Situ Hybridization Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization
- By Application:
- Cancer Diagnosis
- Immunology
- Neuroscience
- Cytology
- Infectious Diseases
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the In Situ Hybridization Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
In situ hybridization is a technique used to identify and localize specific DNA sequences in a sample. The sequence of the DNA can be identified by using probes that are complementary to the target sequence. The probe is then inserted into the sample and allowed to hybridize with the target sequence. After washing away any non-specifically bound material, the probe will remain specifically attached to any strands of DNA that it has hybridized with. This information can then be used to identify and locate specific sequences in the sample.
Some of the major players in the in situ hybridization market are Abbott Laboratories, Roche, Thermo Fisher Scientific, Merck, Agilent Technologies, Perkin Elmer, Danaher, Exiqon, Biogenex Laboratories, Advanced Cell Diagnostics, Bio Sb.
The in situ hybridization market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 In Situ Hybridization Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 In Situ Hybridization Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 In Situ Hybridization Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the In Situ Hybridization Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global In Situ Hybridization Market Size & Forecast, 2018-2028
4.5.1 In Situ Hybridization Market Size and Y-o-Y Growth
4.5.2 In Situ Hybridization Market Absolute $ Opportunity
Chapter 5 Global In Situ Hybridization Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 In Situ Hybridization Market Size Forecast by Type
5.2.1 Fluorescence In Situ Hybridization (FISH)
5.2.2 Chromogenic In Situ Hybridization
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global In Situ Hybridization Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 In Situ Hybridization Market Size Forecast by Applications
6.2.1 Cancer Diagnosis
6.2.2 Immunology
6.2.3 Neuroscience
6.2.4 Cytology
6.2.5 Infectious Diseases
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global In Situ Hybridization Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 In Situ Hybridization Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America In Situ Hybridization Analysis and Forecast
9.1 Introduction
9.2 North America In Situ Hybridization Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America In Situ Hybridization Market Size Forecast by Type
9.6.1 Fluorescence In Situ Hybridization (FISH)
9.6.2 Chromogenic In Situ Hybridization
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America In Situ Hybridization Market Size Forecast by Applications
9.10.1 Cancer Diagnosis
9.10.2 Immunology
9.10.3 Neuroscience
9.10.4 Cytology
9.10.5 Infectious Diseases
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe In Situ Hybridization Analysis and Forecast
10.1 Introduction
10.2 Europe In Situ Hybridization Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe In Situ Hybridization Market Size Forecast by Type
10.6.1 Fluorescence In Situ Hybridization (FISH)
10.6.2 Chromogenic In Situ Hybridization
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe In Situ Hybridization Market Size Forecast by Applications
10.10.1 Cancer Diagnosis
10.10.2 Immunology
10.10.3 Neuroscience
10.10.4 Cytology
10.10.5 Infectious Diseases
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific In Situ Hybridization Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific In Situ Hybridization Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific In Situ Hybridization Market Size Forecast by Type
11.6.1 Fluorescence In Situ Hybridization (FISH)
11.6.2 Chromogenic In Situ Hybridization
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific In Situ Hybridization Market Size Forecast by Applications
11.10.1 Cancer Diagnosis
11.10.2 Immunology
11.10.3 Neuroscience
11.10.4 Cytology
11.10.5 Infectious Diseases
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America In Situ Hybridization Analysis and Forecast
12.1 Introduction
12.2 Latin America In Situ Hybridization Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America In Situ Hybridization Market Size Forecast by Type
12.6.1 Fluorescence In Situ Hybridization (FISH)
12.6.2 Chromogenic In Situ Hybridization
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America In Situ Hybridization Market Size Forecast by Applications
12.10.1 Cancer Diagnosis
12.10.2 Immunology
12.10.3 Neuroscience
12.10.4 Cytology
12.10.5 Infectious Diseases
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) In Situ Hybridization Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) In Situ Hybridization Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) In Situ Hybridization Market Size Forecast by Type
13.6.1 Fluorescence In Situ Hybridization (FISH)
13.6.2 Chromogenic In Situ Hybridization
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) In Situ Hybridization Market Size Forecast by Applications
13.10.1 Cancer Diagnosis
13.10.2 Immunology
13.10.3 Neuroscience
13.10.4 Cytology
13.10.5 Infectious Diseases
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 In Situ Hybridization Market: Competitive Dashboard
14.2 Global In Situ Hybridization Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Roche
14.3.3 Thermo Fisher Scientific
14.3.4 Merck
14.3.5 Agilent Technologies
14.3.6 Perkin Elmer
14.3.7 Danaher
14.3.8 Exiqon
14.3.9 Biogenex Laboratories
14.3.10 Advanced Cell Diagnostics
14.3.11 Bio Sb
